Continuous administration of dopa decarboxylase inhibitors...

Details Continuous administration of dopa decarboxylase inhibitors... Continuous administration of dopa decarboxylase inhibitors...

2011-01-04

2011-01-04

Padmanabhan, Sreeni (Department: 1627)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Nitrogen containing other than solely as a nitrogen in an...

C514S565000, C514S567000, C514S534000

Reexamination Certificate

active

07863336

ABSTRACT:
Disclosed herein are compositions that include for example the arginine salt of carbidopa, and methods for treating neurological or movement diseases or disorders such as restless leg syndrome, Parkinson's disease, secondary parkinsonism, Huntington's disease, Parkinson's like syndrome, PSP, MSA, ALS, Shy-Drager syndrome and conditions resulting from brain injury including carbon monoxide or manganese intoxication, using substantially continuous administration of carbidopa or salt thereof together with administration of levodopa.

REFERENCES:
patent: 3936495 (1976-02-01), Sullivan, Jr.
patent: 4241082 (1980-12-01), Baba et al.
patent: 4409233 (1983-10-01), Tsukada et al.
patent: 4642316 (1987-02-01), Fawzi et al.
patent: 4684666 (1987-08-01), Haas
patent: 4826875 (1989-05-01), Chiesi
patent: 5861423 (1999-01-01), Caldwell et al.
patent: 6245917 (2001-06-01), Bosch et al.
patent: 6500867 (2002-12-01), Virkki et al.
patent: 6620432 (2003-09-01), Addicks et al.
patent: 7309719 (2007-12-01), Aomatsu
patent: 2008/0051459 (2008-02-01), Nyholm et al.
patent: 2008/0255235 (2008-10-01), Segrell
patent: 1077692 (2001-02-01), None
patent: WO-0054773 (2000-09-01), None
patent: WO-2005099678 (2005-10-01), None
patent: WO-2006/006929 (2006-01-01), None
Hirano et al. J. Biochem, 2008, vol. 144, No. 3, pp. 363-369.
Redenti et al. Journal Of Pharmaceutical Sciences, 2001, vol. 90, No. 8, pp. 979-986.
Mehlisch et al. J. Clin. Pharmacol., 2002, vol. 42, pp. 904-911.
Nahata, et al., (2000) “Development of Two Stable Oral Suspensions of Levodopa-Carbidopa for Children with Amblyopia,” J. Pediatric Opthal. & Strab., 37:333-337.
Nyholm, D. (2006) “Enteral Levodopa/Carbidopa Gel Infusion for the Treatment of Motor Fluctuations and Dyskinesias in Advanced Parkinson's Disease,” Expert Review of Neurotherapeutics, 6(10): 1403-1411.

Affiliated with

Also associated with

Rating

Continuous administration of dopa decarboxylase inhibitors... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Continuous administration of dopa decarboxylase inhibitors..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Continuous administration of dopa decarboxylase inhibitors... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2717104